Autophagy/Cytotoxicity Dual Staining Kit
Be the first to review this product! Submit a review
|
(6 Publications)
- FuncS
Supplier Data
Functional Studies - Autophagy/Cytotoxicity Dual Staining Kit (AB133075)
Tamoxifen increases autophagy but not cell death in HepG2 cells (fluorescence microscopy). HepG2 cells were seeded at a density of 5 x 104 cells/well and incubated O/N at 37°C. The next day, cells were treated with either vehicle (panel A & B) or 10 μM of tamoxifen for 24 hours. On the third day, cells were stained with PI and MDC as described in the assay protocol.
Panel A : MDC staining of HepG2 cells treated with vehicle. There is a basal level of autophagy, indicated by faint silver dot staining of autophagic vacuoles. Panel B : PI staining of HepG2 cells treated with vehicle. There are few dead cells with only background staining of propidium iodide.
Panel C : MDC staining of HepG2 cells treated with 10 µM Tamoxifen. There is a clear increase in fluorescence intensity and number of autophagic vacuoles compared to the control cells treated with vehicle. Panel D : PI staining of HepG2 cells treated with 10 µM Tamoxifen, shows similar staining pattern to that of cells treated with vehicle.
- FuncS
Supplier Data
Functional Studies - Autophagy/Cytotoxicity Dual Staining Kit (AB133075)
Tamoxifen increases autophagy but not cell death in HepG2 cells. HepG2 cells were seeded in a 96-well plate at a density of 5 x 104 cells/well in EMEM culture medium and incubated O/N at 37°C. The next day, cells were treated with increasing concentrations of tamoxifen and incubated O/N. On the third day, cells were stained with PI and MDC (as described in the assay protocol) and fluorescence was quantified using a plate reader.
Top panel : Tamoxifen treatment increases MDC fluorescence intensity, indicating that Tamoxifen treatment leads to an increase in autophagy in HepG2 cells.
Bottom panel : Tamoxifen treatment does not cause an increase in PI staining, indicating that at the concentrations used in this experiment, tamoxifen does cause cytotoxicity in HepG2 cells.
Product details
Autophagy/Cytotoxicity Dual Staining Kit (ab133075) provides a convenient tool for studying the regulation of autophagy and cytotoxicity at the cellular level. The kit employs monodansylcadaverine (MDC), a fluorescent compound that is incorporated into multilamellar bodies by both an ion trapping mechanism and the interaction with membrane lipids, as a probe for detection of autophagic vacuoles in cultured cells. Propidium iodide (PI) is used as a marker of cell death. Tamoxifen, a known inducer of autophagy, is included as a positive control. This kit provides sufficient reagent to effectively treat/stain 960 individual wells of cells when utilized in a 96-well plate format. Lower density plates will still require approximately the same amount of reagent on a per plate basis. Therefore, up to 10 plates worth of cells can be examined irrespective of the number of wells/plate (this is not the case for protocols that use non-adherent cells).
Autophagy is a critical cellular process that involves the degradation and digestion of intracellular components by the lysosome. This process not only enables cells to efficiently mobilize and recycle cellular constituents, but also prevents the accumulation of damaged organelles, misfolded proteins, and invading microorganisms.
Autophagy is a multi-step process that begins with the sequestration of cytoplasmic organelles and proteins. These cellular components are sequestered by a double membrane, forming an autophagosome. The autophagosome then fuses with a lysosome to form an autolysosome, where the cellular material is then degraded. Normal autophagy is essential for survival, differentiation, development, and homeostasis. Dysregulation of autophagy has been implicated in cancer, infection, aging, and degenerative diseases.
While autophagy most often acts to promote cell survival in response to stress, it can also promote cell death. The relationship between autophagy and apoptosis is complex. The two pathways share common stimuli and components, and can regulate the activity of each other. However, the specific factors and mechanisms that dictate the choice between autophagy and apoptosis remain unclear.
What's included?
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Autophagy protects cells by degrading and recycling components therefore preventing accumulation of damaged proteins and organelles. It forms part of the cellular defense mechanisms against stress and aging contributing to cellular longevity. In starvation conditions autophagy provides an internal source of nutrients helping cell survival. The process is part of a larger complex involving ATG proteins which drive the sequential steps of autophagosome formation. Monodansylcadaverine an autofluorescent compound often marks autophagic vacuoles in experimental settings providing a tool for autophagy detection and study.
Pathways
Autophagy is deeply integrated into cellular signaling networks. It plays a significant role in the mTOR (mechanistic target of rapamycin) signaling pathway which senses nutrient availability and regulates cell growth. Autophagy also intersects with the AMPK (AMP-activated protein kinase) pathway which responds to energy stress promoting catabolism when cellular ATP levels drop. These intersections with mTOR and AMPK pathways illustrate autophagy's essential role in balancing anabolic and catabolic processes and its regulatory association with proteins involved in cellular stress responses like p62/SQSTM1.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download websiteProtocolBooklet|en
Target data
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
Bioengineering & translational medicine 10:e10741 PubMed40385549
2025
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicines 11: PubMed38137519
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 14:140 PubMed36805591
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 23: PubMed35563174
2022
Applications
Unspecified application
Species
Unspecified reactive species
American journal of physiology. Lung cellular and 317:L525-L536 PubMed31411059
2019
Applications
Unspecified application
Species
Unspecified reactive species
Osteoarthritis and cartilage 22:1936-46 PubMed25168363
2014
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com